BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
This Quarter Return
+8.6%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$152M
AUM Growth
+$152M
(-2.6%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-7.07%
Top 10 Holdings %
Top 10 Hldgs %
76.82%
Holding
24
New
8
Increased
2
Reduced
4
Closed
10
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$13.3M |
| 2 |
Boston Scientific
BSX
|
$11M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$10.8M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$10.7M |
| 5 |
Molina Healthcare
MOH
|
$10.2M |
Top Sells
| 1 |
Cooper Companies
COO
|
$14.3M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$12.9M |
| 3 |
Integra LifeSciences
IART
|
$12.1M |
| 4 |
QGENF
QIAGEN NV
QGENF
|
$10.6M |
| 5 |
STJ
St Jude Medical
STJ
|
$10.5M |
Sector Composition
| 1 | Healthcare | 91.95% |
| 2 | Consumer Staples | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $13.9M | 9.12% |
305,630
-50,880
| -14% | -$2.31M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.3M | 8.72% |
+328,430
| New | +$13.3M |
|
|
MJN
3
DELISTED
Mead Johnson Nutrition Company
MJN
| $12.3M | 8.05% |
135,045
-31,325
| -19% | -$2.84M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11.8M | 7.78% |
152,253
+77,253
| +103% | +$6.01M |
|
5
Masimo
MASI
$7.39B
| $11.5M | 7.55% |
218,960
+65,404
| +43% | +$3.43M |
|
|
ABMD
6
DELISTED
Abiomed Inc
ABMD
| $11.5M | 7.53% |
104,920
-18,670
| -15% | -$2.04M |
|
|
7
Boston Scientific
BSX
$159B
| $11M | 7.21% |
+469,900
| New | +$11M |
|
|
8
Vertex Pharmaceuticals
VRTX
$102B
| $10.8M | 7.09% |
+125,450
| New | +$10.8M |
|
|
9
Ironwood Pharmaceuticals
IRWD
$210M
| $10.7M | 7.05% |
+821,070
| New | +$10.7M |
|
|
10
Molina Healthcare
MOH
$9.62B
| $10.2M | 6.73% |
+205,270
| New | +$10.2M |
|
11
Biogen
BIIB
$20.7B
| $9.67M | 6.35% |
+40,000
| New | +$9.67M |
|
|
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
| $9.54M | 6.26% |
+159,660
| New | +$9.54M |
|
|
AGN
13
DELISTED
Allergan plc
AGN
| $8.54M | 5.61% |
+36,940
| New | +$8.54M |
|
|
SHPG
14
DELISTED
Shire pic
SHPG
| $7.56M | 4.96% |
41,060
-4,090
| -9% | -$753K |
|
15
Agilent Technologies
A
$35.3B
| – | – |
-250,000
| Closed | -$9.96M |
|
|
16
Cooper Companies
COO
$13.2B
| – | – |
-92,690
| Closed | -$14.3M |
|
17
Quest Diagnostics
DGX
$19.9B
| – | – |
-92,949
| Closed | -$6.64M |
|
|
18
Integra LifeSciences
IART
$1.13B
| – | – |
-180,000
| Closed | -$12.1M |
|
19
Incyte
INCY
$16.9B
| – | – |
-85,000
| Closed | -$6.16M |
|
|
20
Ionis Pharmaceuticals
IONS
$9.68B
| – | – |
-318,490
| Closed | -$12.9M |
|
|
PDCO
21
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-142,600
| Closed | -$6.64M |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-45,000
| Closed | -$6.27M |
|
|
STJ
23
DELISTED
St Jude Medical
STJ
| – | – |
-190,140
| Closed | -$10.5M |
|
|
QGENF
24
DELISTED
QIAGEN NV
QGENF
| – | – |
-475,000
| Closed | -$10.6M |
|